Antitumor activity of MDV3100 in a phase I/II study of castration-resistant prostate cancer (CRPC) Meeting Abstract


Authors: Scher, H. I.; Beer, T. M.; Higano, C. S.; Taplin, M.; Efstathiou, E.; Anand, A.; Hung, D.; Hirmand, M.; Fleisher, M.
Abstract Title: Antitumor activity of MDV3100 in a phase I/II study of castration-resistant prostate cancer (CRPC)
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 237s
Language: English
ACCESSION: WOS:000276606603415
PROVIDER: wos
DOI: 10.1200/jco.2009.27.15_suppl.5011
Notes: Meeting Abstract: 5011 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Fleisher
    312 Fleisher
  2. Howard Scher
    1130 Scher
  3. Aseem Anand
    61 Anand